Market Overview:
Market Research Future (MRFR) predicts the global vitamin K2 market size to touch USD 228.27 million by 2023. It can expand at 31.08% CAGR from 2018 to 2023 (forecast period). The alarming cases of vitamin deficiency is expected to be the primary driver of the market. According to the Food and Agriculture Organization of the United Nations (FAO), vitamin K deficiency bleeding (VKDB) in infants has become a serious concern. This can create opportunities for the market.
Increasing rate of vitamin deficiency disorders has created the need for nutraceuticals or supplements inclusive of vitamin K2. In addition, benefits of the vitamin which can reduce the possibility of bone and cardiovascular disorders is likely to spur market growth. High incidence of osteoporosis which prevents formation of new tissues can be treated with regular supply of vitamins
Access Complete Report Details and Infographics @ https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495
Competitive Analysis:
• Kyowa Hakko Bio Co. Ltd
• DSM
• Gnosis SpA
• Frutarom
• Kappa Bioscience
• Danisco A/S
• Seebio Biotech
• NattoPharma
• Viridis BioPharma
Segmentation Analysis:
• The global vitamin K2 market is segmented by product type, source, form, and application.
• By product type, MK-7 accounted for 71.61% market share in 2017, followed by MK-4 (21.87%) and others (6.52%). The MK-7 segment can touch a value of USD 165.91 million by 2023.
• By source, natural accounted for 64.88% share and synthetic accounted for 35.12% share in 2017 respectively.
• By form, powder held 52.75% share in 2017, followed by oil (36.96%) and others (10.29%). The powder form can accrue revenue worth USD 117.89 million by 2023, exhibiting 30.62% CAGR during the review period.
• Among applications, nutraceutical & food accounted for 85.46% share in 2017, while pharmaceutical held 14.54% share. The pharmaceutical segment can exhibit 32.05% CAGR during the forecast period to generate USD 34.69 million for the vitamin K2 market by 2023.
Regional Analysis:
Geographically, the vitamin K2 market is segmented into Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). Americas dominated the market with 42.93% market share in 2017, followed by Europe (38.87%), APAC (14.65%), and MEA (3.55%).
The APAC region can generate close to USD 31.11 million by 2023, growing at 29.51% CAGR over the forecast period. This can be attributed to its huge consumption by the population in China, India, and Australia.
On the other hand, the Europe vitamin K2 market can reach a valuation of USD 94.50 million by 2023. It can exhibit the fastest CAGR of 32.45% during the assessment period. The Americas region can generate 97.01 million by 2023 owing to youth and geriatric populace focused on safeguarding their health. The MEA region can experience a modest growth rate owing to government-backed campaigns which emphasize on citizen wellness.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]